3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Breast Neoplasms
12
Neoplasms
7
Fatigue
6
Prostatic Neoplasms
5
Lung Neoplasms
5
Motor Activity
4
Lymphedema
4
Hematologic Neoplasms
4
Pain
3
Trismus
2
Peripheral Nervous System Diseases
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Neoplasm Metastasis
2
Glioma
2
Esophageal Neoplasms
2
Cachexia
2
Breast Neoplasms, Male
2
Urologic Neoplasms
1
Urinary Incontinence
1
Urinary Bladder Neoplasms
1
Transcranial Magnetic Stimulation, Repetitive
1
Thrombosis
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Sleep Initiation and Maintenance Disorders
1
Shoulder Pain
1
Sarcoma, Synovial
1
Sarcoma, Ewing
1
Interventions
Cisplatin
30
Magnetic Resonance Spectroscopy
21
Radiotherapy
20
pembrolizumab
18
Specimen Handling
17
Cetuximab
16
Radiotherapy, Intensity-Modulated
11
Paclitaxel
11
Carboplatin
11
Fluorouracil
10
Biopsy
10
1,2-diaminocyclohexaneplatinum II citrate
10
Radiation
9
Platinum
9
Drug Therapy
9
Taxes
7
Surgical Procedures, Operative
7
Celecoxib
7
X-Rays
6
Standard of Care
6
Sentinel Lymph Node Biopsy
6
Surveys and Questionnaires
5
Nivolumab
5
cemiplimab
4
Metformin
4
Fluorodeoxyglucose F18
4
Docetaxel
4
Chemoradiotherapy
4
(225)Ac-DOTA-c(RGDyK)
4
durvalumab
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Mouth Neoplasms
×
Physical Therapy Modalities
×
Clear all
NCT00780312
2013-07-02
HOHF
Rigshospitalet, Denmark
Phase 2
Completed
97 enrolled